Literature DB >> 23829603

Gastric cancer: decreasing incidence but stable survival in the Netherlands.

Anneriet E Dassen1, Johan L Dikken, Koop Bosscha, Michel W J M Wouters, Annemieke Cats, Cornelis J H van de Velde, Jan-Willem Coebergh, Valery E P P Lemmens.   

Abstract

BACKGROUND: Gastric cardia and non-cardia cancer exhibit differences in biological and epidemiological features across the world. The aims of this study were to analyze trends in incidence, stage distribution, and survival over a 20-year period in the Netherlands, separately for both types of gastric cancer.
METHODS: Data on all patients with a diagnosis of gastric cancer in the period 1989-2008 were obtained from the nationwide Netherlands Cancer Registry. Time trends in incidence [analyzed as European Standard Rate per 100 000 (ESR)] and relative survival were separately analyzed for cardia and non-cardia gastric cancer.
RESULTS: A total of 47 295 patients were included. Incidence rates per 100 000 for cardia cancer declined from 5.7 to 4.3 for males and remained stable for females (1.2). For non-cardia cancer, the incidence in males declined from 25 to 14 and in females from 10 to 7. Proportional incidence in stage IV cardia and non-cardia cancer increased in 2004-2008 (cardia 32-42%, non-cardia 33-45%). Five-year survival rates for stage I-III and X (unknown) remained stable (cardia cancer: 20%, non-cardia gastric cancer: 31%). Five-year survival for stage IV disease was 1.9% and 1.0% for cardia and non-cardia gastric cancer.
CONCLUSION: The incidence of gastric cancer in the Netherlands markedly decreased over the past decades, in particular of non-cardia cancer. Survival remained dismal. Improvement of survival remains a challenge for the multidisciplinary team involved in gastric cancer treatment.

Entities:  

Mesh:

Year:  2013        PMID: 23829603     DOI: 10.3109/0284186X.2013.789139

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  16 in total

Review 1.  Multimodal treatment of gastric cancer in the west: Where are we going?

Authors:  Daniele Marrelli; Karol Polom; Giovanni de Manzoni; Paolo Morgagni; Gian Luca Baiocchi; Franco Roviello
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

2.  Gastric cancer in three relatives of a patient with a biallelic IL12RB1 mutation.

Authors:  Ingrid P Vogelaar; Rachel S van der Post; Esther van de Vosse; J Han J M van Krieken; Nicoline Hoogerbrugge; Marjolijn J L Ligtenberg; Encarna Gómez García
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

3.  Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort.

Authors:  Willem J Koemans; Robin J Lurvink; Cecile Grootscholten; Rob H A Verhoeven; Ignace H de Hingh; Johanna W van Sandick
Journal:  Gastric Cancer       Date:  2021-01-25       Impact factor: 7.370

4.  Curcumin inhibits proliferation of gastric cancer cells by impairing ATP-sensitive potassium channel opening.

Authors:  Xiaohong Liu; Kai Sun; Ailin Song; Xiaoyun Zhang; Xu Zhang; Xiaodong He
Journal:  World J Surg Oncol       Date:  2014-12-19       Impact factor: 2.754

5.  Phase II study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer.

Authors:  Anneriet E Dassen; Nienke Bernards; Valery E P P Lemmens; Yes A J van de Wouw; Koop Bosscha; Geert-Jan Creemers; Hans J F M Pruijt
Journal:  World J Gastrointest Surg       Date:  2016-10-27

6.  Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study.

Authors:  Rosa T van der Kaaij; Hidde Jw Braam; Henk Boot; Maartje Los; Annemieke Cats; Cecile Grootscholten; Jan Hm Schellens; Arend Gj Aalbers; Alwin Dr Huitema; Catherijne Aj Knibbe; Djamila Boerma; Marinus J Wiezer; Bert van Ramshorst; Johanna W van Sandick
Journal:  JMIR Res Protoc       Date:  2017-07-13

7.  High Mortality Rate of Stomach Cancer Caused Not by Highzzm321990Incidence but Delays in Diagnosis in Aomori Prefecture, Japan

Authors:  Masashi Matsuzaka; Rina Tanaka; Yoshihiro Sasaki
Journal:  Asian Pac J Cancer Prev       Date:  2016-10-01

Review 8.  Updates on Cancer Epidemiology in Korea, 2018.

Authors:  Sun-Seog Kweon
Journal:  Chonnam Med J       Date:  2018-05-25

9.  Sex hormone-binding globulin (SHBG) is a potential early diagnostic biomarker for gastric cancer.

Authors:  Chao-Wen Cheng; Che-Chang Chang; Yudha Nur Patria; Ruei-Ting Chang; Yun-Ru Liu; Fu-An Li; Hsiu-Ming Shih; Ching-Yu Lin
Journal:  Cancer Med       Date:  2017-11-17       Impact factor: 4.452

10.  The association between biliary tract inflammation and risk of digestive system cancers: A population-based cohort study.

Authors:  Tsung-Yu Tsai; Che-Chen Lin; Cheng-Yuan Peng; Wen-Hsin Huang; Wen-Pang Su; Shih-Wei Lai; Hsuan-Ju Chen; Hsueh-Chou Lai
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.